Search Results
Nov 05, 2025, 09:00 ET Fziomed Initiates Commercialization of Oxiplex Gel in the United States
Oxiplex available in the U.S. provides spine surgeons with a new, evidence-based tool to address a significant unmet clinical need," said Alfred L. Rhyne, MD, orthopedic surgeon specializing in the diagnosis and treatment of spine conditions at OrthoCarolina (Charlotte, NC). "Patients will now benefit from
More news about: Fziomed, Inc.
Nov 05, 2025, 09:00 ET McCormick® Redesigns Its Gourmet Line of Premium Herbs & Spices
best in quality from around the world HUNT VALLEY, Md., Nov. 5, 2025 /PRNewswire/ -- The McCormick® brand announces a new look for the
More news about: McCormick & Company
Nov 05, 2025, 09:00 ET ProRx Introduces New Liquid Nanoemulsion Delivery System to Support Enhanced Absorption, Bioavailability, and Patient Convenience
"In my medical practice, we see patients—who have been on injectables for years—excited about these oral therapies," said Cindy Zughbi, MD., medical director at Vitality Health of South Florida. "Previously, the therapeutical effect of other oral and topical testosterone has been very low.
More news about: ProRx Pharma
Nov 05, 2025, 09:00 ET RXNT, a TIME Top HealthTech Company, Launches a Native AI Ambient Listening Platform Built with 26 Years of Clinical Insights
physician efficiency across specialties. ANNAPOLIS, Md., Nov. 5, 2025 /PRNewswire/ -- RXNT, a Maryland-based healthcare technology company, today announced the official
More news about: RXNT
Nov 05, 2025, 08:38 ET CarMax, Inc. (KMX) Faces Securities Class Action Amid Problems with Q2 Growth, Unexpected $142 Million Loss Provision -- Hagens Berman
Nov. 5, 2025 /PRNewswire/ -- A securities fraud class action, styled Cap v. CarMax, Inc., et al., No.1:25-cv-03602-JKB (D. Md.) seeks to represent investors who purchased or otherwise acquired publicly traded CarMax, Inc. (NYSE: KMX) securities between June 20, 2025 and
More news about: Hagens Berman Sobol Shapiro LLP
Nov 05, 2025, 08:30 ET Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting
Francisco)Co-authors: PICI Investigators David Y. Oh, MD, PhD (University of California, San Francisco); Alexander Marson, MD, PhD (Gladstone Institutes); Justin Eyquem, PhD (University of California, San Francisco); Brian Shy, MD, PhD (University of California, San Francisco)
More news about: Parker Institute for Cancer Immunotherapy
Nov 05, 2025, 08:30 ET Enhancing Cardiometabolic Trials with Configurable eCOA and Digital Health Technologies, Upcoming Webinar Hosted by Xtalks
Clinical ink, Nicholas Alp, MD, PhD, FACC, Chief Medical Officer; Steve Polyak, PhD, SVP, Head of Global Product Innovation; Bill Barrasso, MBA, Chief Compliance Officer; Jennifer Guild,
More news about: Xtalks
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
efficacy of investigational oral semaglutide 25 mg as a potential therapeutic option for people with obesity and overweight," said Domenica Rubino, MD, trial investigator and Director, Washington Center for Weight Management and Research in Washington, DC. "It's exciting to see these new results
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
efficacy of investigational oral semaglutide 25 mg as a potential therapeutic option for people with obesity and overweight," said Domenica Rubino, MD, trial investigator and Director, Washington Center for Weight Management and Research in Washington, DC. "It's exciting to see these new results
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:08 ET Tennessee Oncology Opens Early-Phase Clinical Research Unit
Greco-Hainsworth Centers for Research early phase unit led by Jeffery Russell, MD, PhD, MBA and Joseph Merriman, MD As an extension of Tennessee Oncology's Clinical Trials Program, the early phase clinical trials in community
More news about: Tennessee Oncology
Nov 05, 2025, 08:01 ET PracticeCore, the first MSO Dedicated Exclusively to Neurosurgery, Brain, and Spine Care
Matthew J. McGirt, MD, Chief Medical Officer and Practicing Neurosurgeon. "Documentation detail drives prior-auth approvals; surgical decisions shape coding specificity
More news about: PracticeCore
Nov 05, 2025, 08:00 ET 93rd Annual Brunswick Veterans Day Parade Scheduled for November 9, 2025
of Oldest Veterans Day Events in the Nation BRUNSWICK, Md. , Nov. 5, 2025 /PRNewswire/ -- The City of Brunswick is proud of its history and patriotism, which can be
More news about: Brunswick Veterans Day Parade
Nov 05, 2025, 08:00 ET Volta Medical Brings Volta AF-Xplorer™ II to the U.S., Ushering in a New Era of AI in Ablation for Complex Atrial Fibrillation
performance Volta Medical demonstrated in the TAILORED-AF trial." Procedures with AF-Xplorer II were performed by Devi Nair, MD, Director of Cardiac Electrophysiology at St. Bernard's Heart & Vascular Center. "This next-generation technology represents a meaningful step forward
More news about: Volta Medical
Nov 05, 2025, 07:38 ET CGI reports fourth quarter and Fiscal 2025 results
titled Risk Environment of CGI's annual and quarterly MD&A, which is incorporated by reference in this cautionary statement. We also caution readers that the above-mentioned risks and the risks disclosed in CGI's annual and quarterly MD&A and other documents and filings are not the only ones
More news about: CGI Inc.
Nov 05, 2025, 07:00 ET Aurora Cannabis Announces Fiscal 2026 Second Quarter Results
included under the heading "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" in the FY26 Q2 MD&A is incorporated by reference into this news release. The MD&A is available on the Company's issuer profiles on SEDAR+ at
More news about: Aurora Cannabis Inc.
Nov 05, 2025, 07:00 ET NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance
under FDA review. "This NCH-Caristo collaboration represents a new paradigm in cardiovascular medicine," said Dee Dee Wang, MD, Section Head of Cardiac Imaging at NCH Rooney Heart Institute. "Doctors are used to responding to cardiac events after they happen. Caristo has the
More news about: CARISTO DIAGNOSTICS
Nov 05, 2025, 07:00 ET Ceva Partners with Microchip Technology to Enable AI Acceleration Across Edge Devices and Data Center Infrastructure
broad portfolio of Ceva's NeuPro™ NPUs ROCKVILLE, Md., Nov. 5, 2025 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for
More news about: Ceva, Inc.
Nov 05, 2025, 06:30 ET Workers' Compensation Benchmarking Study Launches 2025 Survey Examining New Claim Differentiators in an Evolving Industry
Denise Algire, Director of Health | Albertsons Companies Marcos Iglesias, MD, Chief Medical Director | AF Group Paul Kearney, Chief Claims Officer | AF Group Robert Biltz, VP,
More news about: Rising Medical Solutions LLC
Nov 05, 2025, 06:30 ET Choice Hotels International Reports Third Quarter 2025 Results
Franchise Agreements Awarded by 54% NORTH BETHESDA, Md., Nov. 5, 2025 /PRNewswire/ --
More news about: Choice Hotels International, Inc.
Nov 05, 2025, 06:00 ET Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
Chimovits, MBA, MSc; Jason Coloma, PhD, MBA; Tim Lohoff, PhD; David Malek, MBA; and Travis Murdoch, MD. Board Observers include Vineeta Agarwala, MD, PhD; Evan Caplan, MBA, MD; and Neel Varshney, MD. "Braveheart is an exciting company with an excellent team and real potential to
More news about: Braveheart Bio
Nov 05, 2025, 05:27 ET AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES FIRST BRIDGE FUNDING AWARDS TO SUSTAIN CRITICAL PARKINSON'S RESEARCH
in support. "This program reflects APDA's deep commitment to the scientists behind the breakthroughs," said Rebecca Gilbert, MD, PhD, Chief Mission Officer, APDA. "When researchers face abrupt funding losses, their critical work, and sometimes their careers, can be derailed. We
More news about: American Parkinson Disease Association, Inc.
Nov 05, 2025, 03:40 ET Netcore Cloud Disrupts Global Martech with First Agentic Marketing Platform Offering Pay-for-Performance Pricing
acceleration aligning software costs directly with results delivered. Rajesh Jain, Founder & MD, Netcore Cloud, "Martech has been broken for too long, too many tools, too little impact. We're fixing that. With variable pricing, brands only
More news about: Netcore Cloud
Nov 04, 2025, 19:58 ET Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity Index™ to be Presented at the San Antonio Breast Cancer Symposium
critical to understand when making treatment decisions for breast cancer patients," said Chief Medical Officer at Delphi Diagnostics, Federico A. Monzon, MD. Delphi Diagnostics remains committed to advancing science that ensures patients receive the most effective care possible. Additional
More news about: Delphi Diagnostics Inc
Nov 04, 2025, 19:00 ET Multiple Research Results from Innovent's General Biomedicine Pipeline Showcased at 2025 ACR Annual Meeting
and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Lilly, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center. Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard
More news about: Innovent Biologics
Nov 04, 2025, 16:58 ET DataTribe Announces $3 Million Seed Investment in Rilevera
rules from a centralized, easy-to-use platform FULTON, Md., Nov. 4, 2025 /PRNewswire/ -- DataTribe, a global cyber foundry that invests in and co-builds next-generation
More news about: DataTribe